Docoh
Loading...

IONS Ionis Pharmaceuticals

News

Pro users get this 30m faster
After Aduhelm Win, Biogen Touts Encouraging Data From Second Alzheimer's Candidate
27 Jul 21
Biotech, News, Health Care, General
Biogen And Ionis Highlight Presentation Of Topline Data From Phase 1b Study Of BIIB080/IONIS-MAPTRx Showing Drug Met Safety And Tolerability Objective At AAIC
26 Jul 21
Biotech, News, Events, General
Biogen Inc. (NASDAQ:BIIB) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced today that topline data from a Phase 1b placebo-controlled, multiple ascending dose clinical study showed that
The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
25 Jul 21
Biotech, Earnings, News, Penny Stocks, Previews, Small Cap, FDA, IPOs, Top Stories, Trading Ideas
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.
Morgan Stanley Maintains Underweight on Ionis Pharmaceuticals, Lowers Price Target to $33
16 Jul 21
News, Price Target, Analyst Ratings
Morgan Stanley analyst David Lebowitz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Underweight and lowers the price target from $35 to $33.
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
14 Jul 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, Top Stories
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13)
Bicycle, Ionis To Develop Targeted Oligonucleotide Therapeutics
13 Jul 21
Biotech, News, Health Care, Contracts, Small Cap, General
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
13 Jul 21
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12)
Bicycle Therapeutics Enters Exclusive License And Collaboration Agreement With Ionis To Develop Targeted Oligonucleotide Therapeutics; Bicycle To Receive $45M Upfront Payment And Is Eligible For Milestone Payments And Royalties
13 Jul 21
Biotech, News, Contracts, General
- Bicycle to receive a total of $45 million upfront from Ionis and is eligible for development, regulatory and commercial milestone payments and royalties - The agreement provides Ionis an exclusive license
Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, June 29, 2021: IONS, PATH, KTOS, BZ, VUZI
30 Jun 21
Hedge Funds, Trading Ideas, General
Ionis Pharmaceuticals (IONS) - 268,748 Shares UiPath (PATH) - 858,129 Kratos Defense & Security Solutions (KTOS) - 50,625 KANZHUN (BZ) - 210,723 Vuzix (VUZI) - 232,063
14 Biotech Stocks To Watch Over The Next 6 Months
23 Jun 21
Biotech, News, Small Cap, FDA, Top Stories, Trading Ideas, General
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks.
The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
8 Jun 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7)
The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact
4 Jun 21
Biotech, News, Penny Stocks, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 3)
The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq
28 May 21
Biotech, News, Penny Stocks, Small Cap, FDA, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27)
Stocks That Hit 52-Week Lows On Thursday
27 May 21
News, Intraday Update, Markets, Movers, Trading Ideas
On Thursday morning, 9 companies achieved new lows for the year.
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
27 May 21
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26)
Stocks That Hit 52-Week Lows On Wednesday
26 May 21
News, Intraday Update, Markets, Movers, Trading Ideas
Wednesday morning, 20 companies set new 52-week lows.
The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing
26 May 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, Top Stories, Pre-Market Outlook
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25)
Stocks That Hit 52-Week Lows On Tuesday
25 May 21
News, Intraday Update, Markets, Movers, Trading Ideas
Tuesday's morning session saw 16 companies set new 52-week lows.
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks
20 May 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19)
Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase
18 May 21
Cryptocurrency, Penny Stocks, Sector ETFs, Small Cap, Markets, Trading Ideas, ETFs
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).

Press releases

Pro users get this 30m faster
Ionis completes enrollment in pivotal NEURO-TTRansform study of eplontersen
29 Jul 21
Press Releases
CARLSBAD, Calif., July 29, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), the leader in RNA-targeted therapies, today announced it has completed enrollment of NEURO-TTRansform, the company's Phase 3
Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
26 Jul 21
Press Releases
CAMBRIDGE, Mass. and CARLSBAD, Calif., July 26, 2021 /PRNewswire/ -- Biogen Inc. (NASDAQ:BIIB) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced today that topline data from a Phase 1b placebo-controlled, multiple
Ionis to hold second quarter 2021 financial results webcast
21 Jul 21
Press Releases
CARLSBAD, Calif., July 21, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced today that it will host a live webcast on Wednesday, August 4th at 11:30 a.m. Eastern Time to discuss its second quarter
Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology
13 Jul 21
News, Contracts, Press Releases
CARLSBAD, Calif., July 13, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that it has entered into an exclusive licensing agreement with Bicycle Therapeutics plc (NASDAQ:BCYC) to increase
Ionis' Chief Scientific Officer C. Frank Bennett, Ph.D., receives Gabbay Award in Biotechnology and Medicine
14 Jun 21
Press Releases
CARLSBAD, Calif., June 14, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that Executive Vice President and Chief Scientific Officer C. Frank Bennett, Ph.D., is a co-recipient of the 23rd
Ionis' antisense therapies in ATTR amyloidosis to be featured at 2021 PNS Annual Meeting
10 Jun 21
Press Releases
CARLSBAD, Calif., June 10, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), the leader in RNA-targeted therapies, today announced that multiple presentations highlighting advances in its ATTR amyloidosis
New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen's Commitment to Innovation in SMA Therapy
10 Jun 21
Analyst Ratings, Press Releases
New data analysis suggests an investigational higher dose of SPINRAZA may lead to clinically meaningful improvements in motor functionA NURTURE study analysis shows 92 percent of children who initiated SPINRAZA treatment
Ionis announces changes to its board of directors at annual meeting of stockholders
2 Jun 21
Press Releases
CARLSBAD, Calif., June 2, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced changes to its board of directors. Joseph Loscalzo, M.D., Ph.D., has been appointed chairman of the board and
Ionis to present at upcoming investor conferences
26 May 21
Press Releases
CARLSBAD, Calif., May 26, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that management will present a company overview at the following virtual investor conferences:
Ionis to present at upcoming investor conferences
6 May 21
Press Releases
CARLSBAD, Calif., May 6, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that management will participate in virtual fireside chats at the following investor conferences:
Ionis to host 2021 virtual annual meeting of stockholders
5 May 21
Press Releases
CARLSBAD, Calif., May 5, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that management will conduct its 2021 virtual Annual Meeting of Stockholders followed by a general corporate